Show simple item record

dc.contributor.authorChavez, Alejandro
dc.contributor.authorPruitt, Benjamin W.
dc.contributor.authorTuttle, Marcelle
dc.contributor.authorCecchi, Ryan J.
dc.contributor.authorWinston, Jordan
dc.contributor.authorTurczyk, Brian M.
dc.contributor.authorTung, Michael
dc.contributor.authorCollins, James J.
dc.contributor.authorChurch, George M
dc.contributor.authorShapiro, Rebecca
dc.date.accessioned2018-08-28T15:43:41Z
dc.date.available2018-08-28T15:43:41Z
dc.date.issued2018-03
dc.identifier.issn0027-8424
dc.identifier.issn1091-6490
dc.identifier.urihttp://hdl.handle.net/1721.1/117584
dc.description.abstractHere, we present a generalized method of guide RNA “tuning” that enables Cas9 to discriminate between two target sites that differ by a single-nucleotide polymorphism. We employ our methodology to generate an in vivo mutation prevention system in which Cas9 actively restricts the occurrence of undesired gain-of-function mutations within a population of engineered organisms. We further demonstrate that the system is scalable to a multitude of targets and that the general tuning and prevention concepts are portable across engineered Cas9 variants and Cas9 orthologs. Finally, we show that the mutation prevention system maintains robust activity even when placed within the complex environment of the mouse gastrointestinal tract.en_US
dc.description.sponsorshipNational Human Genome Research Institute (U.S.) ( Grant P50 HG005550)en_US
dc.description.sponsorshipWyss Institute for Biologically Inspired Engineeringen_US
dc.description.sponsorshipUnited States. Defense Threat Reduction Agency (Grant HDTRA1-15-1-0051)en_US
dc.description.sponsorshipPaul G. Allen Frontiers Groupen_US
dc.publisherNational Academy of Sciences (U.S.)en_US
dc.relation.isversionofhttp://dx.doi.org/10.1073/pnas.1718148115en_US
dc.rightsArticle is made available in accordance with the publisher's policy and may be subject to US copyright law. Please refer to the publisher's site for terms of use.en_US
dc.sourcePNASen_US
dc.titlePrecise Cas9 targeting enables genomic mutation preventionen_US
dc.typeArticleen_US
dc.identifier.citationChavez, Alejandro, Benjamin W. Pruitt, Marcelle Tuttle, Rebecca S. Shapiro, Ryan J. Cecchi, Jordan Winston, Brian M. Turczyk, Michael Tung, James J. Collins, and George M. Church. “Precise Cas9 Targeting Enables Genomic Mutation Prevention.” Proceedings of the National Academy of Sciences 115, no. 14 (March 19, 2018): 3669–3673.en_US
dc.contributor.departmentMassachusetts Institute of Technology. Institute for Medical Engineering & Scienceen_US
dc.contributor.departmentHarvard University--MIT Division of Health Sciences and Technologyen_US
dc.contributor.departmentMassachusetts Institute of Technology. Department of Biological Engineeringen_US
dc.contributor.departmentProgram in Media Arts and Sciences (Massachusetts Institute of Technology)en_US
dc.contributor.mitauthorShapiro, Rebecca Sara
dc.contributor.mitauthorCollins, James J.
dc.contributor.mitauthorChurch, George M
dc.relation.journalProceedings of the National Academy of Sciencesen_US
dc.eprint.versionFinal published versionen_US
dc.type.urihttp://purl.org/eprint/type/JournalArticleen_US
eprint.statushttp://purl.org/eprint/status/PeerRevieweden_US
dc.date.updated2018-08-27T17:44:52Z
dspace.orderedauthorsChavez, Alejandro; Pruitt, Benjamin W.; Tuttle, Marcelle; Shapiro, Rebecca S.; Cecchi, Ryan J.; Winston, Jordan; Turczyk, Brian M.; Tung, Michael; Collins, James J.; Church, George M.en_US
dspace.embargo.termsNen_US
dc.identifier.orcidhttps://orcid.org/0000-0001-8167-7096
dc.identifier.orcidhttps://orcid.org/0000-0002-5560-8246
mit.licensePUBLISHER_POLICYen_US


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record